Saturday 17 October 2026
Export WAT’s income statement to Excel — free account
Waters Corporation
WAT Healthcare Diagnostics & Research
Waters Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.2 billion, up 6.99% from fiscal 2024. In the quarter to June 2026, revenue grew 113.4%, EPS fell 156.3%, free cash flow grew 750.0% and total debt rose 308.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
436.95
7.20
−1.62%
Follow WAT
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
21.09 | 815.38 | 24.37 | 26.40 | 29.49 | 33.06 | 29.24 | 30.18 | 34.48 | 35.20 |
Piotroski F-Score |
7 | 7 | 7 | 6 | 7 | 8 | 4 | 4 | 4 | 5 |
P/S ratio |
5.09 | 6.76 | 6.00 | 6.57 | 6.50 | 8.24 | 6.98 | 6.57 | 7.44 | 7.14 |
Altman Z-Score |
6.09 | 6.08 | 8.30 | 9.22 | 8.87 | 10.72 | 10.21 | 7.60 | 9.34 | 9.63 |
P/FCF ratio |
20.58 | 25.72 | 28.85 | 33.32 | 28.85 | 39.62 | 48.41 | 0.00 | 35.52 | 44.53 |
Altman Z″-Score (non-manufacturers) |
10.07 | 9.42 | 11.24 | 12.03 | 11.16 | 12.15 | 12.39 | 9.35 | 10.20 | 10.00 |
Beneish M-Score |
(2.61) | (3.04) | (2.21) | (2.56) | (2.88) | (2.53) | (2.19) | (2.22) | (2.49) | (2.37) |
P/Operating CF |
63.38 | 81.25 | 80.00 | 82.34 | 57.44 | 105.27 | 104.32 | 84.36 | 91.66 | 137.36 |
P/B ratio |
4.79 | 6.99 | 9.27 | 0.00 | 66.18 | 62.42 | 41.09 | 16.88 | 12.04 | 8.82 |
Price to Tangible BV |
6.32 | 9.49 | 15.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 34.04 |
EV/Sales |
4.57 | 6.11 | 5.76 | 7.08 | 6.82 | 8.57 | 7.33 | 7.21 | 7.88 | 7.25 |
EV/EBITDA |
13.74 | 18.38 | 16.43 | 20.95 | 20.92 | 25.06 | 21.69 | 21.68 | 22.90 | 22.76 |
EV/Operating CF |
15.41 | 20.24 | 23.06 | 26.50 | 20.40 | 31.97 | 35.60 | 35.37 | 30.59 | 35.19 |
EV/FCF |
18.50 | 23.25 | 27.69 | 35.94 | 30.28 | 41.26 | 50.85 | (25.38) | 37.62 | 45.24 |
Quick Ratio |
6.35 | 6.48 | 5.13 | 1.56 | 1.26 | 1.74 | 1.53 | 1.39 | 1.34 | 1.14 |
Current Ratio |
6.99 | 7.04 | 5.93 | 2.22 | 1.74 | 2.39 | 2.24 | 2.22 | 2.11 | 1.73 |
Net Debt/EBITDA |
(1.54) | (1.95) | (0.69) | 1.53 | 0.99 | 0.99 | 1.04 | 1.94 | 1.28 | 0.36 |
Debt/Assets |
36.51% | 35.64% | 30.80% | 61.82% | 42.48% | 48.91% | 46.47% | 49.83% | 35.72% | 18.66% |
Debt/Equity |
0.74 | 0.85 | 0.73 | (7.31) | 5.20 | 4.12 | 3.02 | 2.00 | 0.89 | 0.37 |
Asset Turnover |
0.49 | 0.46 | 0.53 | 0.77 | 0.88 | 0.94 | 0.93 | 0.75 | 0.64 | 0.66 |
Operating CF/Net income |
1.23 | 34.35 | 1.02 | 1.09 | 1.52 | 1.08 | 0.86 | 0.94 | 1.19 | 1.02 |
Capex/Depreciation |
(0.94) | (0.85) | (0.89) | (1.56) | (2.02) | (1.28) | (1.41) | (8.70) | (0.74) | (0.70) |
Interest Coverage |
13.92 | 11.65 | 15.21 | 14.55 | 13.15 | 18.29 | 17.90 | 8.27 | 9.21 | 11.54 |
| 23.92% | 0.90% | 31.24% | 87.67% | 6,576.65% | 231.06% | 162.32% | 77.62% | 42.82% | 29.28% | |
| 11.68% | 0.41% | 13.12% | 18.85% | 19.33% | 23.35% | 22.20% | 16.24% | 13.90% | 13.35% | |
ROIC |
32.80% | 56.11% | 47.17% | 43.10% | 40.52% | 39.14% | 35.26% | 16.70% | 16.50% | 17.17% |
Return on Tangible Assets |
15.11% | 0.51% | 23.22% | 52.02% | 47.85% | 46.30% | 45.36% | 40.08% | 41.67% | 41.45% |
Average Days of Receivables |
82.41 | 84.38 | 85.72 | 89.14 | 88.47 | 80.27 | 88.78 | 86.69 | 90.48 | 95.58 |
Research and Development Expense of Revenue |
5.78% | 5.74% | 5.93% | 5.94% | 5.95% | 6.04% | 5.93% | 5.92% | 6.19% | 6.18% |
Selling, General and Administrative Expense of Revenue |
23.64% | 23.57% | 22.19% | 22.22% | 23.41% | 22.51% | 22.14% | 24.90% | 23.33% | 26.23% |
Intangible Assets out of Total Assets |
0.12 | 0.11 | 0.16 | 0.23 | 0.25 | 0.22 | 0.20 | 0.42 | 0.41 | 0.37 |
Share Based Compensation of Revenue |
1.89% | 1.71% | 1.55% | 1.60% | 1.56% | 1.07% | 1.43% | 1.25% | 1.51% | 1.71% |
Graham Net Nets |
0.12 | 0.08 | 0.03 | (0.09) | (0.08) | (0.05) | (0.05) | (0.09) | (0.05) | (0.02) |
Graham Number |
64.41 | 12.30 | 59.54 | 0.00 | 26.57 | 38.91 | 47.29 | 69.07 | 86.38 | 102.24 |
Earnings Yield |
4.74% | 0.12% | 4.10% | 3.79% | 3.39% | 3.02% | 3.42% | 3.31% | 2.90% | 2.84% |
Free Cash Flow Yield |
4.86% | 3.89% | 3.47% | 3.00% | 3.47% | 2.52% | 2.07% | (4.33%) | 2.82% | 2.25% |
Revenue per Share |
26.83 | 28.94 | 31.43 | 35.59 | 38.09 | 45.24 | 49.55 | 50.04 | 49.86 | 53.19 |
Operating CF per Share |
7.96 | 8.74 | 7.85 | 9.51 | 12.73 | 12.14 | 10.20 | 10.20 | 12.84 | 10.97 |
Capex per Share |
(1.13) | (1.13) | (1.25) | (2.42) | (4.07) | (2.73) | (3.06) | (24.43) | (2.40) | (2.44) |
Free Cash Flow per Share |
6.83 | 7.61 | 6.60 | 7.09 | 8.66 | 9.40 | 7.14 | (14.22) | 10.44 | 8.53 |
Cash per Share |
34.82 | 42.53 | 22.54 | 4.99 | 7.14 | 9.25 | 8.03 | 6.70 | 5.48 | 9.88 |
Shareholders Equity per Share |
28.49 | 27.99 | 20.36 | (3.20) | 3.74 | 5.97 | 8.41 | 19.47 | 30.82 | 43.04 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
28.49 | 27.99 | 20.36 | (3.20) | 3.74 | 5.97 | 8.41 | 19.47 | 30.82 | 43.04 |
Free Cash Flow |
551.95 | 607.17 | 508.37 | 479.26 | 537.58 | 579.01 | 428.21 | (840.18) | 619.64 | 507.60 |
Working Capital |
3,115.12 | 3,663.98 | 2,214.23 | 721.16 | 596.05 | 948.43 | 978.17 | 963.29 | 879.35 | 908.15 |
Capital Expenditures |
(90.97) | (90.47) | (96.08) | (163.82) | (252.93) | (168.27) | (183.46) | (1,442.99) | (142.48) | (144.96) |
Net Current Asset Value |
1,275.34 | 1,179.57 | 503.00 | (1,460.84) | (1,206.74) | (1,098.44) | (1,013.06) | (1,723.65) | (1,056.18) | (367.66) |
EV/EBIT |
15.86 | 21.32 | 18.84 | 24.06 | 24.98 | 29.07 | 24.93 | 26.08 | 28.21 | 28.61 |
Capex to Sales |
0.04 | 0.04 | 0.04 | 0.07 | 0.11 | 0.06 | 0.06 | 0.49 | 0.05 | 0.05 |
Price to Operating Income |
17.63 | 23.58 | 19.63 | 22.30 | 23.80 | 27.92 | 23.74 | 23.74 | 26.64 | 28.16 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.29 | 0.30 | 0.32 | 0.25 | 0.25 | 0.24 | 0.22 | 0.26 | 0.29 | 0.32 |
Cash ROIC |
8.10% | 8.07% | 11.42% | 28.16% | 28.57% | 23.63% | 17.05% | (21.81%) | 16.39% | 12.39% |
Accounts Receivable Turnover |
4.53 | 4.51 | 4.39 | 4.16 | 4.07 | 4.70 | 4.45 | 4.15 | 4.12 | 4.05 |
Accounts Payable Turnover |
12.89 | 14.32 | 14.96 | 17.25 | 16.61 | 13.69 | 13.13 | 13.43 | 13.00 | 12.65 |
Inventory Turnover |
3.39 | 3.55 | 3.53 | 3.30 | 3.22 | 3.50 | 3.08 | 2.46 | 2.42 | 2.46 |
Average Days of Payables |
27.74 | 24.87 | 25.07 | 17.70 | 26.18 | 30.55 | 27.28 | 25.87 | 30.39 | 29.39 |
Days of Inventory on Hand |
107.55 | 104.17 | 107.22 | 115.76 | 110.32 | 112.38 | 133.26 | 157.65 | 145.14 | 162.10 |
Average Receivables |
478.83 | 511.58 | 551.07 | 578.03 | 580.53 | 592.98 | 667.77 | 712.53 | 717.77 | 781.10 |
Average Payables |
69.16 | 66.14 | 66.35 | 58.58 | 60.61 | 84.51 | 95.05 | 89.00 | 92.32 | 101.85 |
Average Inventory |
263.05 | 266.49 | 280.93 | 306.06 | 312.42 | 330.19 | 405.90 | 485.97 | 496.75 | 524.82 |
Average Assets |
4,465.37 | 4,993.21 | 4,525.89 | 3,142.24 | 2,698.49 | 2,967.43 | 3,188.19 | 3,954.15 | 4,590.32 | 4,815.17 |
Average Common Equity |
2,180.40 | 2,267.87 | 1,900.52 | 675.49 | 7.93 | 299.85 | 436.02 | 827.41 | 1,489.42 | 2,194.87 |
Columns are period end dates